CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Releases Q3 2019 Financial and Operating Results

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, on Thursday released its third quarter 2019 financial and operating results. According to the update, VIVO’s net revenue increased to $6.3 million during Q3 2019, which represents a 19% increase relative to the same period last year. The increase reflects the ramp-up of the company’s licensed capacity, which is expected to generate further revenue growth in Q4 2019. “Our focus for the first half of the year was to satisfy the needs of the evolving adult-use market, provide consistent supply of quality products to medical patients, and execute our plans for cannabis 2.0,” VIVO Chief Executive Officer Barry Fishman said in the news release. “We continue to execute against our four strategic priorities and are sharply focused on accelerating our path to profitability.”

To view the full press release, visit http://cnw.fm/28H7f

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology at its Canna Farms facility in Hope, B.C., and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM). The company is significantly expanding its production capacity and distribution channels; growing its domestic medical cannabis platform, including Harvest Medicine, its patient-centric, highly scalable network of specialty medical cannabis clinics and services; promoting production and cultivation innovation and pursuing partnership and product development opportunities; and actively focusing on growth in select international markets, including Germany and Australia. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VVCIF

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Receives Conditional Approval to Graduate to the Toronto Stock Exchange

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, today announced its receipt of Toronto Stock Exchange (“TSX”) conditional approval to graduate from the TSX Venture Exchange (the “TSXV”) and list its common shares on the TSX. “The TSX is a premier destination for publicly traded companies and this listing represents a significant milestone for VIVO,” Barry Fishman, CEO of VIVO Cannabis, said in the news release. “It also demonstrates our long-term commitment to increasing investor awareness and generating shareholder value as we continue to drive sales in our premium family of brands including Canna Farms(TM), Beacon Medical(TM), Fireside(TM) and Lumina(TM).”

To view the full press release, visit http://cnw.fm/vV4oF

About VIVO Cannabis(TM)

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VVCIF

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Poll Shows Americans Still View Marijuana as Safer Than Alcohol and Electronic Cigarettes

A new poll released on Tuesday by POLITICO and Harvard’s T.H. Chan School of Public Health shows that the majority of Americans believe that alcohol and tobacco are more harmful than marijuana.

Only 1 in every 5 Americans believes marijuana to be harmful to its consumers while 2 in 5 Americans believe alcohol is detrimental to its users. 52% of Americans consider cigarettes to be very dangerous, while 80% say that tobacco is very harmful.

Robert Blendon, the Harvard professor for health policy and political analysis who conducted the poll of 1007 Americans, said that in the past decade, people were being jailed for marijuana, but today, they are saying marijuana is not harmful.

Since the 2012 ballot referendum authorizing recreational marijuana in Colorado and Washington, marijuana legalization is rapidly being adopted by different states across the U.S. Currently there are 33 states in the U.S. that have legalized the use marijuana medically or recreationally. However, marijuana is still categorized as an illegal drug at the federal level.

The poll shows that despite the outbreak of the vaping-related lung illnesses which left 37people dead, people’s perception of marijuana was not affected. THC was present in the vaping products linked with the lung ailments. THC is a compound of cannabis that gives the high effect. According to the survey, some of the vaping products were purchased from the black market, and only a few of the products were purchased through legal channels.

The poll was conducted in October, a month after the outbreak of the vaping related lung illnesses. Blendon said that people have termed vaping as very dangerous, but the same is not true for cannabis.

During the poll, almost half the participants did not know what CBD is. Among the 8% of the adult participants familiar with the product, 5% said that the product is very harmful. Most of those familiar with CBD said that the federal government should not interfere with the product. And half of those said that the Food and Drug Administration should oversee the safety of products infused with CBD.

Fifty-five percent of those familiar with CBD said they would buy CBD over the counter regardless of whether those products passed or failed clinical trials. And, 3 out of 5 Americans said that they would still use their favorite products, even after the FDA confirms that it does not fulfill its intended purpose.

Blendon said that people do not perceive CBD as harmful; so, the FDA regulations of this cannabinoid should not be stringent.

Federal legalization of marijuana is supported by 67% of the Democrats, 69% of the independents, and 45% of the Republicans, which translates to 62 percent of all Americans. This is a marked increase from 44% in 2009, said Blendon.

Analysts believe that it is opinion poll findings like these which make marijuana companies, such as LiveWire Ergogenics Inc. (OTC: LVVV) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF), to wonder why the federal government is so out of touch with the sentiments of the citizens.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Enters Technology and Research Partnership with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF)

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, has entered into a technology and multi-phase research agreement with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF) (“CB2”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community. Under the agreement, CB2 will assist in the development of VIVO’s global medical product development strategy. CB2 will integrate its Clinical Data Management Software (“CDMS”) and Electronic Data Capture (“EDC”) tools to establish a better understanding of VIVO’s current medical patient registry, and the companies will collaborate on a comprehensive research strategy to validate the safety and efficacy of current products. “CB2’s global experience in clinical research and technology will enable VIVO to enhance our understanding of Canadian medical patients. This will facilitate our uncovering of new ways to meet the expectations of our current patients and will help inform our international growth plans,” VIVO CEO Barry Fishman said in the news release. “At VIVO, our purpose is to help patients achieve a positive quality of life with cannabis. We look forward to utilizing our partnership with CB2 to further bring real world evidence to the medical cannabis industry.”

To view the full press release, visit http://cnw.fm/C6Pwd

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Connecticut Lawmakers Approve More Medical Marijuana Qualifying Conditions

The lawmakers in Connecticut have allowed more medical marijuana qualifying conditions. On Tuesday, the General Assembly Regulations Review Committee added five qualifying conditions for adults. Two of the five conditions are intractable neuropathic pain and Tourette syndrome. Patients under the age of 18 with the two ailments were are also approved to use medical marijuana.

In a written statement, Michelle H. Seagull, the Consumer Protection Commissioner, thanked the members of the Regulations Review Committee and the Board of Physicians for the addition of the qualifying conditions. She further said that it is good to know that medical marijuana will be available to more patients who are suffering from debilitating diseases. Seagull is also looking forward to working on the program.

The regulations will be submitted to the Secretary of State’s office to be finalized, and then posted online.

In addition to the two approved conditions, the General Assembly Regulations Review Committee also approved interstitial cystitis, median arcuate ligament syndrome and vulvodynia, and vulva burning. Chronic pain was approved by the Medical Marijuana Program Board as a qualifying condition last month; however, the Regulations Review Committee did not vote for it on Tuesday.

In Connecticut, 37,080 patients are participating in the medical marijuana program. Currently, there 36 qualifying conditions for adult patients and ten qualifying conditions for patients under the age of 18.

There are 15 medical marijuana dispensaries and four producers licensed to operate within the state. Three more dispensaries are in the process of being opened after they were issued with licenses.

The medical marijuana program was launched in 2012. At that time, there were only 11 qualifying conditions. These included cancer, glaucoma, and PTSD (post-traumatic stress disorder). The program has expanded over the years to include other conditions such as cystic fibrosis, cerebral palsy, muscular dystrophy, and other terminal illnesses that require end of life care.

The legislators approved Medical marijuana for minors in 2016, and their qualifying conditions included severe epilepsy and uncontrolled intractable seizure disorder.

The state approval process is still ongoing for the additional qualifying conditions so it is expected that as more information becomes available regarding other conditions which can be managed using medical marijuana, the responsible body will receive testimony on the same and add those conditions without having to involve the lawmakers.

This approach of modifying the list of qualifying conditions without the seeking approval from lawmakers I a good one because it saves a lot of time and sidesteps partisan politics which can at times derail otherwise good programs.

One is led to imagine that marijuana companies like The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) must be glad that the pool of patients who can benefit from medical marijuana in Connecticut has been widened.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Former FDA Boss Calls for Federal Regulation of Marijuana Markets

On Monday, Scott Gottlieb, the former Food and Drug Administration Commissioner, said that the federal government should be given the authority to regulate states’ marijuana programs.

In a CNBC appearance, Scott Gottlieb said that the increase in vaping related lung illnesses calls for the need of a federal regulatory system that would give the agencies power to enforce industry standards on all facets of the legal cannabis market such as the potency of THC and the proper methods of consumption.

Although the official was previously not clear on the extent of federal government involvement citing that the vaping problems are due to conflicts between the state and federal laws– he did not say which would be his preferred policy fix. However, last week in a Wall Street Journal editorial, he provided some clarification by saying that federal drug scheduling laws for marijuana should be reformed to offer limited regulations and promote more research on cannabis.

During a TV interview, Gottlieb said that enforcing marijuana prohibition is not politically practicable anymore and that Congress should approve a federal law that allows the enactment of appropriate supervision by the regulatory authorities.

Although he is not in support of the legalization of recreational marijuana and if possible he would like it to shut down completely, the reality of the situation is that many states have already legalized it; thus, any federal system formed would have to accommodate recreational cannabis.

When he was asked if all the states would be in a position to implement all the regulations he has proposed, Gottlieb said no, because some states do not have the capacity nor the resources to control what is being sold in their legal dispensaries as well as shutting down the black market.

He said that for this to be possible, federal authorities are a necessity.

The regulatory model Gottlieb is envisioning is one where the FDA and agencies such as the Drug Enforcement Administration could control the potency of the products, the manufacturing process, the ingredients, and the purpose for which the products are made.

Gottlieb further added that by federalizing marijuana and allowing recreational consumption, they would be in a position where they can limit the types of cannabis products being sold, their potency, and the forms in which it can be consumed. However, he still thinks vaping products should be banned.

He said that the federal agencies should enact strict measures on medical cannabis while holding them to a higher standard and allowing recreational use of the product with lower concentrations of THC, which poses less harm that vaping e-liquids.

He concludes by saying that compromising is right where you allow some form of recreational consumption of marijuana, which is in low concentration in the states allowing it instead of leaving it as it is today where there are no federal laws governing marijuana in those state-legal markets.

Industry analysts believe that companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) could be seeing lots of sense in the proposals of the former FDA chief.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Reaffirms Timing of First Harvest at Kimmetts, Unveils 2020 Cultivation Plans

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced its expected commencement of the first harvest at its Kimmetts facility in Napanee, Ontario in the fourth quarter of 2019. In addition, VIVO unveiled its plans for the facility in 2020, which include an accelerated planting schedule and the contemplated use of five additional acres of land adjacent to the existing airhouses. VIVO made the announcements during its analyst and investor day held in Napanee, where the company showcased its airhouse technology, extraction programs and progress toward achieving EU GMP certification. “The fact that we expect to be able to commence first harvest within our stated timelines and budget speaks to the early success of the airhouses and the talent of our Napanee team,” VIVO CEO Barry Fishman said in the news release. “Kimmetts is expected to play a significant role in our strategy of bringing new value-added products to market, as well as contributing to our existing collection of premium brands, including Beacon Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM).”

To view the full press release, visit http://cnw.fm/g2Y6y

About VIVO Cannabis(TM)

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Marijuana Legalization Bill Introduced in Pennsylvania

Just a few days after Gov. Tom Wolf (D) announced that he was now in support of legalizing recreational marijuana, a bill has been filed in the state Assembly seeking to create a state-run system through which recreational marijuana can be brought to the state.

Under the legislation introduced by Rep. David Delloso (D), adults 21 or older can possess, consume, purchase and even cultivate marijuana through a stores system run by the state through the Liquor Control Commission.

The text of this proposed law states that the legalization of marijuana is being sought in order to enhance the best use of law enforcement resources, promote personal freedom and avail more revenue in the state purse.

The proposal also includes suggested tax rates for recreational marijuana products. The 19 percent tax collected on sales would be put in the general fund of the state, and a separate regulatory program would be established to oversee industrial hemp.

One notable provision of this draft law seeks to create an avenue through which Pennsylvania would import recreational marijuana products from other states or even countries. However, the existing federal law regards marijuana as a controlled substance that cannot be moved across state lines, which is why companies that operate in different marijuana markets in the U.S. build entirely new systems instead of moving products from one state where they operate to another.

The import provision also creates a condition that other states or countries must meet if they are to engage in recreational marijuana trade with Pennsylvania; those jurisdictions must accept marijuana exports from Pennsylvania.

Oregon was the first to pass such a law providing for interstate commerce in marijuana, but their law had a provision that this mechanism could only be triggered once the federal government changed its laws on marijuana.

In June, Rep. Earl Blumenauer and Sen. Ron Wyden, both Democrats from Oregon, filed similar bills in Congress and the U.S. Senate respectively that would make it possible for states where marijuana is legal to trade in the substance with each other. However, these bills have never been scheduled for hearing.

If this bill is passed, the Liquor Control Commission would be given up to July 1 next year to have regulations ready for the implementation of the recreational marijuana program.

It isn’t yet clear how much support this proposal to run the marijuana program using a state cultivation and distribution model would work since it could put state employees directly in conflict with the federal government that would regard them as “drug traffickers.”

Experts are of the view that industry actors like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB) will be watching to see whether Pennsylvania becomes the first state to run a recreational marijuana system.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Four Easy Steps to Getting Your Arizona Medical Marijuana Card in 2019

In 2013, Phoenix New Times published an article showing people the step by step process of getting their Arizona Medical Marijuana Card. After August 27 of 2019, a new law signed by Governor Doug of Arizona allows patients, caregivers and pharmacy agents to access the medical marijuana card at half the cost. The card gives them the privilege of obtaining medical marijuana for two years instead of one.

The card is accessible by almost every resident of Arizona; therefore, if you are a marijuana consumer, make it a priority to get one of these out-of-jail free cards. Marijuana possession and consumption remains a felony for those who are not patients. Possession of marijuana products is classified as a class four crime, and it is likened to heroin possession and weapons misconduct.

This article gives you a step-by-step guide of the exact processes you need to follow to get your Arizona medical marijuana card.

Find out the Qualifying Conditions

To qualify for the medical cannabis card, you need to have one or more of the following ailments: ALS, Alzheimer’s disease, cancer, chronic pain, cachexia, Crohn’s disease, HIV/AIDS, epilepsy, multiple sclerosis, post-traumatic stress disorder, seizures, or severe nausea. Most of the patients qualifying for the medical card complain of chronic pain together with other ailments, or on its own.

Find a Qualified Medical Marijuana Doctor

Having qualifying conditions is not enough; you still need to find a qualified medical marijuana evaluator to give you a recommendation. You can find MMJ (medical marijuana) evaluators online or in newspapers. The MMJ doctor can be a naturopath, an osteopath or homoeopath who is registered in Arizona. A single visit will cost you $75-$150. If there are no qualifying conditions in your record, the MMJ doctor will refer you to another doctor. The designated doctor, for an additional fee, will provide you with an official diagnosis. People suffering from menstrual cramps and soreness from old injury also qualify for the Arizona medical cannabis card.

Submit Your Application

The Arizonian Department of Health Services (DHS) provides guidelines on the process of submitting applications. You can visit the site https://azdhs.gov/licensing/medical-marijuana/index.php. In earlier days, people used to submit their applications, but in recent times the doctors upload your photo and documentation to the DHS system. As the applicant, you will have to sign a form promising not to sell or misuse your medication. The application will cost you $150, but if you qualify for food assistance, you will only pay $75. If you are issued with the new MMJ card, you will have access to medical marijuana for two years.

Get Your Medical Marijuana

After you have received your medical marijuana card, you can start enjoying the benefits of weed by purchasing from a certified pharmacy near you. You are allowed to buy up to 2.5 ounces of medical cannabis every two weeks. If you live 25 miles or farther from the nearest dispensary, you are allowed to grow a few medical marijuana plants.

A court ruling passed in 2019 prohibits patients from smoking weed in public or a car in a public parking space. The patients should also keep medical marijuana from children.

Possession of the Arizona medical card provides defense against prosecution, but it does not erase state laws governing marijuana. Therefore patients should abide by the rules because breaking them lands you in felony territory. In Arizona, more than 200,000 patients are enjoying the benefits of medical marijuana without fear of being arrested.

Analysts expect the entire marijuana industry, including VIVO Cannabis Inc. (CSE: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB), to applaud the fact that Arizona patients now no longer have to go through the hassles of getting a new card each year.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Canadian Company to Offer First Odorless Marijuana

Are you tired of the strong smell of marijuana? A Canadian company may have the solution you have been looking for if their license application is approved by Health Canada, the regulator of the marijuana industry in the country.

CannabCo Pharmaceuticals, an Ontario-based company, announced last Tuesday that it would launch its odorless marijuana, and the company boasts that it is the first in the world to offer such a product.

CannabCo Pharmaceuticals intends to use a technology that it has named PURECANN to create this odorless marijuana. The company adds that it has exclusive rights to use this technology in Canada.

The PURECANN technology was originally developed for use in the medical marijuana industry in order to eliminate the characteristic harshness associated with smoking marijuana. The technology removes this harshness without affecting the potency of the substance.

The absence of the odor and the harshness makes this new form of marijuana more appealing to beginners who often break out into coughing fits when they try smoking cannabis for the first time.

While the company hasn’t provided any details about how the odorless marijuana will be used, they pointed out that consumers will not have to buy any third-party products or accessories. All that they need is the odorless marijuana.

The first reaction of the people who heard about this odorless marijuana was to say that they are curious to find out what effect removing the odor will have on the potency of the marijuana. Others said that the odor of marijuana is a good indicator of its potency, so it would be interesting to find out what it would be like to smoke that odorless cannabis.

Perhaps the real question now is whether there is a sustainable market for this odorless marijuana. CannabCo Pharmaceuticals is looking at the market of people who hate the smell of marijuana, and this could be a profitable niche whose needs haven’t been addressed by the existing products on the market.

The company is also looking at people who find themselves in environments where the smell of cannabis would be an issue. For example, the smell of cannabis can be a flashpoint if one lives in an apartment block and the smell from his or her joint drifts to nearby units whose occupants are opposed to using marijuana.

Additionally, people who do work that isn’t safety-sensitive and wish to smoke a joint during their lunch break can also benefit from this odorless marijuana since they wouldn’t have to worry that the smell would cling to their clothes and skin.

It would be interesting to know whether industry players like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB) ever imagined that marijuana products would evolve to such an extent that companies now want to offer marijuana without the signature marijuana smell.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com